Interest in the Medium Term of an Infrared Reflexotherapy on Overweight or Class I Obese People (REFLEX-IR)

December 6, 2022 updated by: Jean-Michel Lecerf, Institut Pasteur de Lille
The study aim is to Assess the Effect of an IR Reflexotherapy on Overweight and Class I Obese People.

Study Overview

Study Type

Interventional

Enrollment (Actual)

87

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Nord
      • Lille, Nord, France, 59019
        • NutrInvest - Institut Pasteur de Lille

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • BMI between 27 and 35 kg/m2 (included),
  • Aged 30 to 60 years old (included),
  • Stable weight: no variation of 3 kg in the las 3 months,
  • Signed the consent form,
  • Able to follow the study,
  • Health insured.

Exclusion Criteria:

  • History of coronary disease (in the last 6 months),
  • Progressive illness at the time of the study (cancer, neurodegenerative disease...),
  • Diabetics (treated or not),
  • Fasting blood total cholesterol equal or over 2.5 g/L (treated or not),
  • Fasting blood triglycerides equal or over 2.0 g/L (treated or not),
  • Fasting blood glucose equal or over 1.26 g/L,
  • Peripheral neuropathy (polyneuritis, diabetic neuropathy) or central neuropathy (hemiplegia),
  • Infectious cutaneous condition or allergies (to the contact point of the device),
  • History of stroke,
  • Severe heart disease,
  • Epilepsy,
  • Reduced motility,
  • Diagnosed eating disorder,
  • Followed a diet in the last 90 days in order to lose weight,
  • Took weight loss assistance drug (Orlistat) in the last month or is likely to take one during the study,
  • Psychiatric disorder incompatible with the study,
  • Mental illness,
  • Neurological disorder,
  • Chronic somatic disease,
  • Addiction or nicotine withdrawal,
  • Under psychoactive drug ,
  • Alcool consumption over 3 glasses a day,
  • Pregnant or breastfeeding women,
  • Women that are likely to get pregnant during the study,
  • Is unable to understand or follow the protocol
  • Is deprived of liberty
  • Is under judicial protection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Dietary care
Treatment is composed of a dietary care (with advices on physical activity) given by a professional (dietician of the Nutrition Department of the Institut Pasteur de Lille).
Dietary consultation 1, 2, 3, 6, 9, 12, 15 and 18 months after the beginning of the study
Experimental: IR reflexotherapy + dietary care

Treatment is composed of :

  • IR reflexotherapy sessions given by a trained professional ;
  • dietary care (with advices on physical activity) given by a professional (dietician of the Nutrition Department of the Institut Pasteur de Lille).
Dietary consultation 1, 2, 3, 6, 9, 12, 15 and 18 months after the beginning of the study

18 IR reflexotherapy sessions :

  • Once a week for 12 weeks at the beginning of the study
  • Once a week for 3 weeks, 9 months after the beginning of the study
  • Once a week for 3 weeks, 15 months after the beginning of the study
Experimental: IR Reflexotherapy
Treatment is composed of IR reflexotherapy sessions given by a trained professional.

18 IR reflexotherapy sessions :

  • Once a week for 12 weeks at the beginning of the study
  • Once a week for 3 weeks, 9 months after the beginning of the study
  • Once a week for 3 weeks, 15 months after the beginning of the study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Weight changes after 12 months compared to a dietary care (associated with physical activity advice) dispensed by a professional.
Time Frame: 12 months
12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Effect of infrared (IR) reflexotherapy on weight changes.
Time Frame: 3, 12 and 18 months
3, 12 and 18 months
Effect of IR reflexotherapy combined with a dietary care (and physical activity advises) dispensed by a professional on the weight changes.
Time Frame: 3, 12 and 18 months.
3, 12 and 18 months.
Effect of infrared (IR) reflexotherapy on waist size.
Time Frame: 3, 12 and 18 months
3, 12 and 18 months
Effect of IR reflexotherapy combined with a dietary care (and physical activity advises) dispensed by a professional on the waist siez.
Time Frame: 3, 12 and 18 months.
3, 12 and 18 months.
Effect of infrared (IR) reflexotherapy on dietary habits.
Time Frame: 3, 12 and 18 months
3, 12 and 18 months
Effect of IR reflexotherapy combined with a dietary care (and physical activity advises) dispensed by a professional on dietary habits.
Time Frame: 3, 12 and 18 months.
3, 12 and 18 months.
Effect of infrared (IR) reflexotherapy on life's quality (anxiety, depression, physical impact, psychosocial, impact on sexual life, eating well-being, feeling about the dietary care).
Time Frame: 3, 12 and 18 months
3, 12 and 18 months
Effect of IR reflexotherapy combined with dietary care (and physical activity advises) dispensed by professional on life quality (anxiety, depression, physical impact, psychosocial, impact on sexual life, eating wellbeing, feeling about the dietary care)
Time Frame: 3, 12 and 18 months.
3, 12 and 18 months.
Effect of infrared (IR) reflexotherapy on the salivary cortisol.
Time Frame: 3 months
3 months
Effect of IR reflexotherapy combined with a dietary care (and physical activity advises) dispensed by a professional on the salivary cortisol.
Time Frame: 3 months.
3 months.
Effect of infrared (IR) reflexotherapy on blood pressure and heart rate.
Time Frame: 3 months
3 months
Effect of IR reflexotherapy combined with a dietary care (and physical activity advises) dispensed by a professional on blood pressure and heart rate.
Time Frame: 3 months.
3 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Jean-Michel LECERF, MD, Institut Pasteur de Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 18, 2013

Primary Completion (Actual)

January 28, 2016

Study Completion (Actual)

January 28, 2016

Study Registration Dates

First Submitted

November 26, 2013

First Submitted That Met QC Criteria

November 26, 2013

First Posted (Estimate)

December 3, 2013

Study Record Updates

Last Update Posted (Estimate)

December 8, 2022

Last Update Submitted That Met QC Criteria

December 6, 2022

Last Verified

December 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2013-A00800-45

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dietary care

3
Subscribe